G1 Ther­a­peu­tics joins a grow­ing biotech win­ners cir­cle with $105M IPO

G1 Ther­a­peu­tics is now the lat­est in a string of biotech IPOs to start out with a hit on its price range. The Re­search Tri­an­gle Park, NC-based out­fit raised $105 mil­lion by sell­ing 7 mil­lion shares at $15 each. That’s the bot­tom of the range, but that qual­i­fies as an­oth­er suc­cess­ful out­ing for the lat­est in a slate of biotechs find­ing a rel­a­tive­ly warm re­cep­tion on Wall Street af­ter a fair­ly chilly Q1.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER